Developments towards tissue-engineered, small-diameter arterial substitutes

Expert Review of Medical Devices

Volumn 5, Issue 3, 2008, Pages 337-347

  Bordenave, Laurence ^a,b,c,d   Menu, Patrick ^e   Baquey, Charles ^c,d  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b Centre of Clinical Investigation Clinical Epidemiology   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Biomaterial; Bioreactor; Endothelial cell; Scaffold; Small diameter vascular substitution; Stem cell; Vascular graft; Vascular tissue engineering

Indexed keywords

BIOMATERIAL; POLITEF; POLY ALPHA HYDROXYESTER; POLYANHYDRIDE; POLYCAPROLACTONE; POLYETHYLENE TEREPHTHALATE; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYMER; UNCLASSIFIED DRUG;

ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTERY ENDOTHELIUM; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOREACTOR; BLOOD VESSEL GRAFT; BLOOD VESSEL TONE; CELL DIFFERENTIATION; CELL PROLIFERATION; CRYOPRESERVATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GRAFT PATENCY; GRAFT PRESERVATION; HEMOSTASIS; HUMAN; LEUKOCYTE ADHERENCE; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; TISSUE ENGINEERING; VASCULAR SMOOTH MUSCLE; ARTERY; BLOOD VESSEL PROSTHESIS;

ARTERIES; BLOOD VESSEL PROSTHESIS; HUMANS; TISSUE ENGINEERING;

EID: 48649091049     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.5.3.337     Document Type: Review

References (104)

1. Vara DS, Salacinski HJ, Kannan RY et al. Cardiovascular tissue engineering: state of the art. Pathol. Biol. 53, 599-612 (2005).
2. Abbott WM, Green RM, Matsumoto T et al.; Above-Knee Femoropopliteal Study Group. Prosthetic above-knee femoropophteal bypass grafting: results of a multicenter randomized prospective trial. J. Vasc. Surg. 25, 19-28 (1997).
3. Klinkert P, Post PN, Breslau PJ et al. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur. J. Vasc. Endovasc. Surg. 27, 357-362 (2004).
4. Kashyap VS, Ahn SS, Quinones-Bald rich WJ et al. Infrapopliteal-lower extremity revascularization with prosthetic conduit: a 20-year experience. Vasc. Endovasc. Surg. 36, 255-262 (2002).
5. Baguneid MS, Seifalian AM, Salacinski HJ et al. Tissue engineering of blood essels. Br. J. Surg. 93, 282-290 (2006).
6. Abbott WM, Megerman J, Hasson JE et al. Effect of compliance mismatch on vascular graft patency. J. Vasc. Surg. 5, 376-382 (1987).
7. Ao PY, Hawthorne WJ, Vicaretti M, Fletcher JP. Development of intimal hyperplasia in six different vascular prostheses. Eur. J. Vasc. Endovasc. Surg. 20, 241-249 (2000).
8. Chervu A, Moore WS. An overview of intimal hyperplasia. Surg. Gynecol. Obstet. 171, 433-447 (1990).
9. Bos GW, Poot AA, Beugeling T et al. Small-diameter vascular graft prostheses: current status. Arch. Physiol. Biochem. 106, 100-115 (1998).
10. Wusteman MC, Pegg DE, Warwick RM. The banking of arterial allografts in the United kingdom. A technical and clinical review. Cell Tissue Bank 1, 295-301 (2000).
11. Song YC, Khirabadi BS, Lightfoot F et al. Vitreous cryopreservatiom maintains the function of vascular grafts. Nat. Biotechnol. 18, 296-299 (2000).
12. Marois Y, Wagner E, Pitris E et al. Comparaison of healing in fresh and served arterial allograts in the dog. Ann. Vasc. Surg. 13, 130-140 (1999).
13. Adham M, Gournier JP, Favre J P et al. Mechanical characteristics of fresh and frozen human descending thoracic aorta. J. Surg. Res. 64, 32-34 (1996).
14. Stanke F, Riebel D, Carmine S et al. Functional assessment of human femoral arteries after cryopreservation. J. Vasc. Surg. 28, 273-283 (1998).
15. Venkatasurbramanian RT, Grassl ED, Baroca VH et al. Effects of freezing and cryop reservation on the mechanical properties of arteries. Ann. Biomed. Eng. 34, 823-832 (2006).
16. Farber A, Major K, Wagner WH et al. Cryopreserved saphenous vein allografts in infrainguinal revascularization: analysis of 240 grafts. J. Vasc. Surg. 38, 15-21 (2003).
17. Foster ED, Kranc MAT. Alternative conduits for aortocoronary bypass grafting. Circulation 79, 34-39 (1989).
18. Thomas AC, Gordon R, Campbell R et al. Advances in vascular tissue engineering. Cardiovasc. Pathol. 12, 271-276 (2003).
19. Conte MS. The ideal small arterial substitute: a search for the holy grail? FASEB J. 12, 43-45 (1998).
20. Kirkpatrick CJ, Wagner M, Hermanns I et al. Physiology and cell biology of the endothelium: a dynamic interface for cell communication. Inter. J. Microcirc. 17, 231-240 (1997).
21. Herring MB, Gardner A, Glover J. A single staged technique for seeding vascular grafts with aurologous endothelium. Surgery 84, 498-504 (1978).
22. Herring MB, Baughman S, Glover JL. Endothelium develops on seeded human at terial prostheses: a brief clinical note. J. Vasc. Surg. 2, 727-730 (1985).
23. Sauvage LR, Berger K, Beilin LB et al. Presence of endothelium in an axillary-femoral graft of knitted Dacron with an external surface. Ann. Surg. 182, 759-763 (1975).
24. Hong-De-Wu MH, Shi Q, Wechezack AR et al. Definitive proof of endothelialization ofa Dacron aterial prosthesis in a human being. J. Vasc. Surg. 21, 862-867 (1995).
25. Shi Q, Hong-De-Wu MH, Onuki Y et al. Endothelium on the flow surface of human aortic Dacron vascular grafts. Cardiovasc. Surg. 25, 736-742 (1997).
26. Abbott WM, Vignati JJ. Prosthetic grafts: when are they a reasonable alternative? Sim. Vasc. Surg. 8(3) 236-245 (1995).
27. Wilson GJ, MacGregor DC, Klement P et al. Anisotropic polyurethane nonwoven conduits: a new approach to the design of a vascular prothesis. Trans. Am. Soc. Artif. Intern. Organs 24(XXIX), 260-268 (1983).
28. Langer R, Vacanti JP. Tissue engineering. Science 260, 920-926 (1993).
29. Baquey C, Dupuy B. Hybrid Artificial Organs: concepts and development. In: Colloque INSERM. Les Editions Inserm 177 (1989).
30. Rabkin E, Schoen FJ. Cardiovascular tissue engineering. Cardiovasc. Pathol. 11, 305-317 (2002).
31. Atala A, Bauer SB et al. Tissue-engineered autologous bladders for patients needing cytoplasty. Lancet 367(9518), 1215-12161 (2006).
32. Langer R. Editorial: tissue engineering: perspectives, challenges, and future directions. Tissue Eng. 13(1), 1-2 (2007).
33. Meinhart JG, Deutsch M, Fischlein T et al. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann. Thorac. Surg. 71, S327-S331 (2001).
34. Naito Y, Imai Y, Shin'oka T et al. Successful clinical application of tissue-engineered graft for extracardiac Fontan operation. J. Thorac. Cardiovasc. Surg. 125, 419-420 (2003).
35. Shin'oka T, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N. Engl. J. Med. 344, 532-533 (2001).
36. Matsumura G, Hibino N, Ikada Y et al. Successful application of tissue-engineered vascular autografts: clinical experience. Biomaterials 24, 2303-2308 (2003).
37. Shin'oka T, Matsumura G et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J. Thorac. Cardiovasc. Surg. 129(6), 1330-1338 (2005).
38. L'Heureux N, McAllister TN, De La Fuente LM. Tissue-engineered blood vessel for adult arterial revascularization. N. Engl. J. Med. 357(14), 1451-1453 (2007).
39. Vacanti JP. Editorial: tissue engineering: a 20-year personal perspective. Tissue Eng. 13(2), 231-232 (2007).
40. L'Heureux N, Dusserre N et al. The evolution of tissue-engineered vascular grafts - from research to clinical practice. Nat. Clin. Prac. Cardiovasc. Med. 4(7), 389-395 (2007).
41. Vesely I. Heart valve tissue engineering. Circ. Res. 99(4), 743-755 (2005).
42. Mendelson K, Schoen FJ. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann. Biomed. Eng. 34(12), 1799-1819 (2006).
43. Riha GM, Lin PH, Lumsden AB et al. Application of stem cells for vascular tissue engineering. Tissue Eng. 11(9/10), 1535-1552 (2005).
44. Freed LA, Guilak F, Guo E et al. Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Eng. 12(12), 3285-3305 (2006).
45. Yow KH, Ingram J, Korossis SA et al. Tissue engineering of vascular conduits. Br. J. Surg. 93, 652-661 (2006).
46. Boccaccini A, Blaker JJ. Bioactive composite materials for tissue engineering scaffolds. Expert. Rev. Med. Devices 2(3), 303-317 (2005).
47. Sparks CH. Silicone mandril method of femoropopliteral artery bypass. Clinical experience and surgical technics. Am. J. Surg. 124, 244-249 (1972).
48. Roberts PN, Hopkinson BR et al. The sparks mandril in femoropopliteal bypass. Br. Med. J. 1190-1191 (1977).
49. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 231, 397-400 (1986).
50. Salacinski HJ, Tai NR, Carson RJ et al. In vitro stability of a novel compliant poly(carbonate-urea) urethane to oxidative and hydrolytic stress. J. Biomed. Mater. Res. 59, 207-218 (2002).
51. Tiwari A, Salacinski H, Seifalian A et al. New prostheses for use in bypass grafts with special emphasis on polyurethanes. Cardiovasc. Surg. 10, 191-197 (1998).
52. Kannan RY, Salacinski HJ et al. The degradative resistance of polyhedral oligomeric silesquioxane nanocore integrated polyurethanes: an in vitro study. Biomaterials 27(9), 1971-1979 (2005).
53. Kannan RY, Salacinski HJ et al. The antithrombogenic potential of a polyhedral oligomeric silesquioxane (POSS) nanocomposite. Biomacromolecules 7(1), 215-223 (2006).
54. Tiaw KS, Teoh SH et al. Processing methods of ultrathin poly(epsilon-caprolactone) films for tissue engineering applications. Biomacromolecules 8(3), 807-816 (2007).
55. Amiel GE, Komura M et al.Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells. Tissue Eng. 12(83), 2355-2365 (2006).
56. Lantz GC, Badylak SF, Hiles MC et al. Small intestinal submucosa as a vascular graft: a review. J. Invest. Surg. 6, 297-310 (1993).
57. L'heureux N, Paquet S, Labbe R et al. A completely biological tissue-engineered human blood vessel. FASEB J. 12, 47-56 (1998).
58. L'Heureux N, Dusserre N et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat. Med. 12(3), 361-365 (2006).
59. Stegemann JP, Kaszuba SN et al. Review: advances in vascular tissue engineering using protein-based biomaterials. Tissue Eng. 13(11), 2601-2613 (2007).
60. Schmidt CE, Baier JM. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 21, 2215-2231 (2000).
61. Hodde J. Naturally occuring scaffolds for soft tissue repair and regeneration. Tissue Eng. 8, 295-308 (2002).
62. Kerdjoudj H, Moby V, Berthelemy N et al. The ideal small arterial substitute: role of cell seeding and tissue engineering. Clin. Hemorheol. Microcirc. 37(1-2), 89-98 (2007).
63. Campbell JH, Efendy JL, Campbell GR. Novel vascular graft grown within recipient's own peritoneal cavity. Circ. Res. 85, 1173-1178 (1999).
64. Xue L, Greisler HP. Biomaterials in the development and future of vascular grafts. J. Vasc. Surg. 37, 472-480 (2003).
65. Kerdjoudj H, Boura C, Moby V et al. Re-endothelialization of human umbilical arteries treated with a polyelectrolyte multilayer film: a tool for damaged arteries replacement. Adv. Funct. Mat. Volume 17(15), 2667-2673 (2007).
66. Hersel U, Dahmer. C, Kesler H. RGD modified polymers: biomaterials; for stimulated cell adhesion and beyond. Biomaterials 24(24), 4385-4415 (2003).
67. Tassiopoulos A, Greisler HP. Angiogenic mechanisms of endothelialization of cardiovascular implants: a review of recent investigative strategies. J. Biomater. Sci. Polymer. Edn. 11(11), 1275-1284 (2000).
68. Fernandez P, Deguette A, Pothuaud L et al. Quality control assessment of ePTFE precoating procedure for in vitro endothelial cell seeding. Biomaterials 26(24), 5042-5047 (2005).
69. Lutolf MP Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23(1), 47-55 (2005).
70. Evans ND, Gentleman E, Polak JM. Scaffolds for stem cells. Materials Today. 9(12), 26-33 (2006).
71. Phasn QP, Sharma U, Mikos AG. Electrospinning of polymeric nantifibers for tissue engineering applications: a review. Tissue Eng. 12(15, 1197-1211 (2006).
72. Murugan R, Ramakrishna S. Nano-featured scaffolds for tissue engineering: a review of spinning methodologies. Timm Eng. 12(3), 435-447 (2006).
73. Teo WE, He W, Ramakrishna S. Electrospun scaffold tailored for tissue-specific extracellular matrix. Biotechnol. J. 1, 918-929 (2006).
74. Buttafoco L, Kolkman NG et al. Electrospinning of collagen and elastin for tissue engineering applications. Biomaterials 27(5), 724-734 (2006).
75. McManus MC, Boland ED et al. Mechanical properties of electrospun fibrinogen structures. Acta Biomater. 2(1), 19-28 (2006).
76. Niklason LF, Gao J, Abbott WM et al. Functional arteries grown in vitro. Surgery 98, 816-823 (1985).
77. Opitz F. Schenke-Layland K, Cohnert TU, Stock UA. Phenotypical plasticity of vascular smooth muscle cells: effect of in vitro and in vivo shear stress for tissue engineering of blood vessels. Tissue Eng. 13(10), 2505-2514 (2007).
78. Quinones-Baldrich WJ et al. Failure of PTFE infrainguinal revascularization: patterns, management alternatives, and outcome. Ann. Vasc. Surg. 5, 163-169 (1991).
79. Fordenave L Temy-Zolghadri M, Fernandez P. et al. Clinical performance of vascular grafts lined with endothelial cells. Endothelium 6(4), 267-275 (1999).
80. Bordenave L, Fernandez P, Remy-Zolghadri M et al. In vitro endothelialized ePTFE prostheses: clinical update 20 years after the first realization. Clin. Hemorheol. Microcirc. 33(3), 227-234 (2005).
81. Shirota T, He H, Yasui H, Matsuda T. Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. Tissue Eng. 9(1), 127-136 (2003).
82. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967 (1997).
83. Levenberg S. Engineering blood vessels from stem cells: recent advances and applications. Cur. Opin. Biotechnol. 16, 516-523 (2005).
84. Sales KM, Salacinski HJ, Alobaid N et al. Advancing vascular tissue engineering: the role of stem cell technology. TRENDS Biotechnol. 23(9), 461-467 (2005).
85. Barrilleaux B, Phinney DG, Prockop DJ et al. Ex vivo engineering of living tissues with adult stem cells. Tissue Eng. 12(11), 3007-3019 (2006).
86. Daculsi R, Remy-Zolghadri M, Grellier M et al. Signal transduction and procoagulant state of human cord blood-progenitor derived endothelial cells after IL-1α stimulation. Endothelium 14, 163-171 (2007).
87. Levenberg S, Zoldan J, Basevitch Y, Langer R. Endothelial potential of human embryonic stem cells. Blood 110(3), 806-814 (2007).
88. Ferreira LS, Gerecht S et al. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ. Res. 101(3), 286-294 (2007).
89. Harris DT, Badowski M, Ahmad N, Gaballa MA. The potential of cord blood stem cells for use in regenerative medicine. Expert. Opin. Biol. Ther. 7(9), 1311-1322 (2007).
90. Flanagan TC, Cornelissen C, Koch S et al. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Biomaterials 28(8), 3388-3397 (2007).
91. Martin I, Wendt D, Heberer M. The role of bioreactors in tissue engineering. TRENDS Biotechnol. 22(2), 80-86 (2004).
92. Hamilton DW, Maul TM, Vorp DA. Characterization of the response of bone marrow-derived progenitor cells to cyclic strain: implications for vascular tissueengineering applications. Tissue Eng. 10(3-4), 361-369 (2004).
93. Yamamoto K, Takahashi T, Asahara T et al. Proliferation, differentiation and tube formation by endothelial progenitor cells in response to shear stress. J. Appl. Physiol. 95(5), 2081-2088 (2003).
94. Nerem RM. Atherogenesis: hemodynamics, vascular geometry, and the endothelium. Biorheol. 21, 565 (1984).
95. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 75, 519-560 (1995).
96. Chien S. Mechanotransduction and endothelial cell homeostasis: the wisdom of the cell. J. Physiol. Heart Circ. Physiol. 292, H1209-H1224 (2005).
97. Fernandez P, Daculsi R, Remy-Zolghadri M et al. Endothelial cells cultured on engineered vascular grafts are able to transduce shear stress. Tissue Eng. 12(1-2), 1-7 (2006).
98. Moby V, Boura C, Kerdjoudj H et al. Poly(styrenesulfonate)/ poly(allylamine) multilayers: a route to favor endothelial cell growth on expanded poly(tetrafluoroethylene) vascular grafts. Biomacromol. 8(7), 2156-2160 (2007).
99. Fernandez P, Bourget C, Bareille R et al. Gene response in endothelial cells cultured on engineered surfaces is regulated by shear stress. Tissue Eng. 13(7), 1607-1614 (2007).
100. Vunjak-Novakovic G, Kaplan DL. Tissue engineering: the next generation. Tissue Eng. 12(12), 3261-3263 (2006).
101. Bock AK, Ibarreta D, Rodriguez-Cerezo. Human Tissue-engineered Products - Today's Markets and Future Prospects. JRC-IPTS - European Commission, Report EUR 21000 EN. October 2003.
102. Meinhart JG, Schense JC, Schima H et al. Enhanced endothelial cell retention on shear-stressed synthetic vascular grafts precoated with RGD-cross-linked fibrin. Tissue Eng. 11(5/6), 887-895 (2005).
103. Alobaid N, Salacinski HJ, Sales KM et al. Nanocomposite containing bioactive peptides promote endothelialization by circulating progenitor cells: an in vitro evaluation. Eur. J. Vasc. Endovasc. Surg. 32(1), 76-83 (2006).
104. Trommelmans L, Selling J, Dierickx K. A critical assessment of the directive on tissue engineering of the European Union. Tissue Eng. 13(4), 667-672 (2007).